Kornitzer Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18M Sell
325,646
-6,229
-2% -$338K 0.39% 57
2025
Q4
$16.3M Sell
331,875
-11,099
-3% -$518K 0.34% 64
2025
Q3
$14.8M Sell
342,974
-1,168
-0.3% -$45.6K 0.3% 79
2025
Q2
$13.2M Sell
344,142
-5,809
-2% -$222K 0.27% 92
2025
Q1
$13.6M Buy
349,951
+3,658
+1% +$134K 0.28% 89
2024
Q4
$11.7M Sell
346,293
-13,874
-4% -$499K 0.23% 119
2024
Q3
$14.7M Buy
360,167
+5,479
+2% +$224K 0.27% 102
2024
Q2
$13.7M Sell
354,688
-1,415
-0.4% -$59.5K 0.26% 104
2024
Q1
$15.3M Sell
356,103
-571
-0.2% -$23.5K 0.28% 105
2023
Q4
$13.2M Sell
356,674
-58,853
-14% -$2.11M 0.26% 111
2023
Q3
$15.1M Sell
415,527
-8,778
-2% -$312K 0.31% 84
2023
Q2
$15.1M Sell
424,305
-99,871
-19% -$3.58M 0.3% 96
2023
Q1
$18.7M Sell
524,176
-1,540
-0.3% -$53.9K 0.37% 73
2022
Q4
$18.5M Sell
525,716
-13,779
-3% -$459K 0.37% 72
2022
Q3
$15.9M Sell
539,495
-18,323
-3% -$694K 0.34% 78
2022
Q2
$30.4M Sell
557,818
-4,085
-0.7% -$226K 0.61% 34
2022
Q1
$30.6M Sell
561,903
-4,001
-0.7% -$217K 0.5% 48
2021
Q4
$31.2M Sell
565,904
-4,694
-0.8% -$244K 0.47% 53
2021
Q3
$27.3M Sell
570,598
-1,574
-0.3% -$79.1K 0.42% 68
2021
Q2
$28.5M Sell
572,172
-82,802
-13% -$3.98M 0.43% 65
2021
Q1
$29.2M Buy
654,974
+3,769
+0.6% +$171K 0.47% 61
2020
Q4
$30M Sell
651,205
-34,353
-5% -$1.58M 0.51% 56
2020
Q3
$32.3M Sell
685,558
-7,336
-1% -$368K 0.63% 32
2020
Q2
$35.3M Buy
692,894
+1,235
+0.2% +$63.4K 0.71% 26
2020
Q1
$32.8M Sell
691,659
-16,215
-2% -$865K 0.78% 24
2019
Q4
$41.6M Sell
707,874
-100,292
-12% -$5.58M 0.73% 26
2019
Q3
$43.1M Sell
808,166
-5,400
-0.7% -$278K 0.78% 24
2019
Q2
$40.7M Buy
813,566
+3,556
+0.4% +$178K 0.72% 28
2019
Q1
$42.3M Sell
810,010
-84,010
-9% -$4.2M 0.76% 25
2018
Q4
$42.7M Sell
894,020
-6,972
-0.8% -$343K 0.85% 21
2018
Q3
$45.2M Buy
900,992
+1,695
+0.2% +$86.1K 0.72% 26
2018
Q2
$45.3M Buy
899,297
+2,305
+0.3% +$116K 0.76% 24
2018
Q1
$43.8M Buy
896,992
+25,956
+3% +$1.21M 0.75% 25
2017
Q4
$38.6M Sell
871,036
-68,507
-7% -$3.16M 0.66% 35
2017
Q3
$47.7M Sell
939,543
-25,992
-3% -$1.32M 0.83% 26
2017
Q2
$52M Sell
965,535
-23,951
-2% -$1.28M 0.91% 16
2017
Q1
$52.1M Buy
989,486
+15,194
+2% +$771K 0.93% 19
2016
Q4
$46.9M Sell
974,292
-11,128
-1% -$550K 0.88% 24
2016
Q3
$53.1M Buy
985,420
+7,280
+0.7% +$399K 0.95% 16
2016
Q2
$53M Buy
978,140
+13,484
+1% +$710K 0.96% 16
2016
Q1
$48.9M Buy
964,656
+10,553
+1% +$526K 0.84% 21
2015
Q4
$48.1M Buy
954,103
+1,536
+0.2% +$78.3K 0.79% 21
2015
Q3
$45.8M Buy
952,567
+40,836
+4% +$2.13M 0.73% 24
2015
Q2
$47.5M Buy
911,731
+9,271
+1% +$522K 0.64% 42
2015
Q1
$52.1M Buy
902,460
+16,804
+2% +$963K 0.63% 50
2014
Q4
$47.3M Buy
885,656
+113,872
+15% +$6.37M 0.55% 64
2014
Q3
$44.3M Buy
771,784
+95,308
+14% +$5.84M 0.51% 70
2014
Q2
$45.2M Buy
676,476
+9,604
+1% +$650K 0.49% 72
2014
Q1
$44.5M Buy
666,872
+13,920
+2% +$941K 0.47% 71
2013
Q4
$43.6M Buy
652,952
+6,664
+1% +$432K 0.47% 70
2013
Q3
$40.5M Sell
646,288
-520
-0.1% -$33.5K 0.47% 71
2013
Q2
$40.4M Buy
+646,808
New +$41.1M 0.53% 63

Other funds holding GSK